Browsing Tag
Tanabe Pharma Corporation
1 post
LEO Pharma bets up to $435m on dersimelagon as rare skin drug nears FDA decision
LEO Pharma will pay up to $435 million in upfront and near-term milestones for global rights to dersimelagon, a Phase 3 rare-disease drug already submitted to the FDA.